Skip to main content
All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q3 amendment for Pierre Fabre Pharmaceuticals Inc. on October 16, 2026, reporting no lobbying activity.

Lobbying for Pierre Fabre Pharmaceuticals Inc. · Pharmaceutical manufacturer

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for PIERRE FABRE PHARMACEUTICALS INC.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Pierre Fabre Pharmaceuticals Inc. has reported

 Filing · LD-2 quarterly report Q3 amendmentNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey

Official filing document

 Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem